Dominic P. Behan
2013
In 2013, Dominic P. Behan earned a total compensation of $2.3M as Executive Vice President, Chief Scientific Officer and Director at Arena Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,900 |
|---|---|
| Option Awards | $392,290 |
| Salary | $420,000 |
| Stock Awards | $1,290,600 |
| Other | $16,041 |
| Total | $2,326,831 |
Behan received $1.3M in stock awards, accounting for 55% of the total pay in 2013.
Behan also received $207.9K in non-equity incentive plan, $392.3K in option awards, $420K in salary and $16K in other compensation.
Rankings
In 2013, Dominic P. Behan's compensation ranked 3,366th out of 12,286 executives tracked by ExecPay. In other words, Behan earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,366 out of 12,286 | 73rd |
Division Manufacturing | 1,137 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 303 out of 1,466 | 79th |
Industry group Drugs | 207 out of 1,160 | 82nd |
Industry Pharmaceutical Preparations | 171 out of 890 | 81st |
Source: SEC filing on April 28, 2016.
Behan's colleagues
We found five more compensation records of executives who worked with Dominic P. Behan at Arena Pharmaceuticals in 2013.
2013
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2013
Steven Spector
Arena Pharmaceuticals
General Counsel
2013
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2013
Robert Hoffman
Arena Pharmaceuticals
Chief Financial Officer
2013
Harry Hixson
Arena Pharmaceuticals